Tomato Bushy Stunt Virus Nanoparticles as a Platform for Drug Delivery to Shh-Dependent Medulloblastoma

• Published in: International journal of molecular sciences 2021-09, Vol.22 (19), p.10523
• Main Authors: Lico, Chiara, Tanno, Barbara, Marchetti, Luca, Novelli, Flavia, Giardullo, Paola, Arcangeli, Caterina, Pazzaglia, Simonetta, Podda, Maurizio S, Santi, Luca, Bernini, Roberta, Baschieri, Selene, Mancuso, Mariateresa
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Binding sites; Brain cancer; Bushy stunt; Cell viability; Central nervous system; Cerebellar Neoplasms - drug therapy; Cerebellar Neoplasms - genetics; Cerebellar Neoplasms - metabolism; Cerebellar Neoplasms - pathology; Doxorubicin; Doxorubicin - chemistry; Doxorubicin - pharmacology; Drug delivery; Drug Delivery Systems; Drug resistance; Genetic engineering; Genomes; Hedgehog Proteins - genetics; Hedgehog Proteins - metabolism; Immunofluorescence; Ligands; Medulloblastoma; Medulloblastoma - drug therapy; Medulloblastoma - genetics; Medulloblastoma - metabolism; Medulloblastoma - pathology; Mice; Mice, Mutant Strains; Molecular dynamics; Nanoparticles; Nanoparticles - chemistry; Nanoparticles - therapeutic use; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; Nicotiana - virology; Peptides; Plant viruses; Proteins; Radiation therapy; Therapeutic targets; Tombusvirus - chemistry; Toxicity; Tumor cells; Tumors; Viruses
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms221910523

Medulloblastoma (MB) is a primary central nervous system tumor affecting mainly young children. New strategies of drug delivery are urgent to treat MB and, in particular, the SHH-dependent subtype-the most common in infants-in whom radiotherapy is precluded due to the severe neurological side effects. Plant virus nanoparticles (NPs) represent an innovative solution for this challenge. Tomato bushy stunt virus (TBSV) was functionally characterized as a carrier for drug targeted delivery to a murine model of Shh-MB. The TBSV NPs surface was genetically engineered with peptides for brain cancer cell targeting, and the modified particles were produced on a large scale using plants. Tests on primary cultures of Shh-MB cells allowed us to define the most efficient peptides able to induce specific uptake of TBSV. Immunofluorescence and molecular dynamics simulations supported the hypothesis that the specific targeting of the NPs was mediated by the interaction of the peptides with their natural partners and reinforced by the presentation in association with the virus. In vitro experiments demonstrated that the delivery of Doxorubicin through the chimeric TBSV allowed reducing the dose of the chemotherapeutic agent necessary to induce a significant decrease in tumor cells viability. Moreover, the systemic administration of TBSV NPs in MB symptomatic mice, independently of sex, confirmed the ability of the virus to reach the tumor in a specific manner. A significant advantage in the recognition of the target appeared when TBSV NPs were functionalized with the CooP peptide. Overall, these results open new perspectives for the use of TBSV as a vehicle for the targeted delivery of chemotherapeutics to MB in order to reduce early and late toxicity.